Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

The surface protein HvgA mediates group B streptococcus hypervirulence and meningeal tropism in neonates.

Tazi A, Disson O, Bellais S, Bouaboud A, Dmytruk N, Dramsi S, Mistou MY, Khun H, Mechler C, Tardieux I, Trieu-Cuot P, Lecuit M, Poyart C.

J Exp Med. 2010 Oct 25;207(11):2313-22. doi: 10.1084/jem.20092594. Epub 2010 Oct 18.

2.

Group B Streptococcus surface proteins as major determinants for meningeal tropism.

Tazi A, Bellais S, Tardieux I, Dramsi S, Trieu-Cuot P, Poyart C.

Curr Opin Microbiol. 2012 Feb;15(1):44-9. doi: 10.1016/j.mib.2011.12.002. Epub 2011 Dec 27. Review.

PMID:
22206860
3.

The group B streptococcal serine-rich repeat 1 glycoprotein mediates penetration of the blood-brain barrier.

van Sorge NM, Quach D, Gurney MA, Sullam PM, Nizet V, Doran KS.

J Infect Dis. 2009 May 15;199(10):1479-87. doi: 10.1086/598217.

4.

[A breakthrough in the understanding of neonatal group B streptococcus meningitis].

Tazi A, Disson O, Bellais S, Bouaboud A, Tardieux I, Trieu-Cuot P, Lecuit M, Poyart C.

Med Sci (Paris). 2011 Apr;27(4):362-4. doi: 10.1051/medsci/2011274010. Epub 2011 Apr 28. French. No abstract available.

5.

BibA: a novel immunogenic bacterial adhesin contributing to group B Streptococcus survival in human blood.

Santi I, Scarselli M, Mariani M, Pezzicoli A, Masignani V, Taddei A, Grandi G, Telford JL, Soriani M.

Mol Microbiol. 2007 Feb;63(3):754-67. Epub 2007 Jan 8.

6.

Identification of a group B streptococcal fibronectin binding protein, SfbA, that contributes to invasion of brain endothelium and development of meningitis.

Mu R, Kim BJ, Paco C, Del Rosario Y, Courtney HS, Doran KS.

Infect Immun. 2014 Jun;82(6):2276-86. doi: 10.1128/IAI.01559-13. Epub 2014 Mar 18.

7.

Group B Streptococcus hijacks the host plasminogen system to promote brain endothelial cell invasion.

Magalhães V, Andrade EB, Alves J, Ribeiro A, Kim KS, Lima M, Trieu-Cuot P, Ferreira P.

PLoS One. 2013 May 2;8(5):e63244. doi: 10.1371/journal.pone.0063244. Print 2013.

8.

Characterization of invasive group B streptococcus strains from the greater Toronto area, Canada.

Teatero S, McGeer A, Low DE, Li A, Demczuk W, Martin I, Fittipaldi N.

J Clin Microbiol. 2014 May;52(5):1441-7. doi: 10.1128/JCM.03554-13. Epub 2014 Feb 19.

9.

Binding of glycoprotein Srr1 of Streptococcus agalactiae to fibrinogen promotes attachment to brain endothelium and the development of meningitis.

Seo HS, Mu R, Kim BJ, Doran KS, Sullam PM.

PLoS Pathog. 2012;8(10):e1002947. doi: 10.1371/journal.ppat.1002947. Epub 2012 Oct 4.

10.

Adult zebrafish model of bacterial meningitis in Streptococcus agalactiae infection.

Patterson H, Saralahti A, Parikka M, Dramsi S, Trieu-Cuot P, Poyart C, Rounioja S, Rämet M.

Dev Comp Immunol. 2012 Nov;38(3):447-55. doi: 10.1016/j.dci.2012.07.007. Epub 2012 Aug 4.

PMID:
22867759
11.

Capsular switching in group B Streptococcus CC17 hypervirulent clone: a future challenge for polysaccharide vaccine development.

Bellais S, Six A, Fouet A, Longo M, Dmytruk N, Glaser P, Trieu-Cuot P, Poyart C.

J Infect Dis. 2012 Dec 1;206(11):1745-52. doi: 10.1093/infdis/jis605. Epub 2012 Sep 21.

PMID:
23002446
12.

Multilocus sequence types associated with neonatal group B streptococcal sepsis and meningitis in Canada.

Manning SD, Springman AC, Lehotzky E, Lewis MA, Whittam TS, Davies HD.

J Clin Microbiol. 2009 Apr;47(4):1143-8. doi: 10.1128/JCM.01424-08. Epub 2009 Jan 21.

13.

Group B streptococcal infection and activation of human astrocytes.

Stoner TD, Weston TA, Trejo J, Doran KS.

PLoS One. 2015 Jun 1;10(6):e0128431. doi: 10.1371/journal.pone.0128431. eCollection 2015 Jun 1.

14.

Recurrent sepsis and neuroinvasive disease in a neonate culture-positive for a Group B Streptococcus CPS III serotype, hvgA+ strain.

Suresh S, Tyrrell G, Alhhazmi A, Escoredo S, Hawkes M.

JMM Case Rep. 2016 Jun 25;3(3):e005034. doi: 10.1099/jmmcr.0.005034. eCollection 2016 Jun 25.

PMID:
28348758
15.
16.

Bacterial induction of Snail1 contributes to blood-brain barrier disruption.

Kim BJ, Hancock BM, Bermudez A, Del Cid N, Reyes E, van Sorge NM, Lauth X, Smurthwaite CA, Hilton BJ, Stotland A, Banerjee A, Buchanan J, Wolkowicz R, Traver D, Doran KS.

J Clin Invest. 2015 Jun;125(6):2473-83. doi: 10.1172/JCI74159. Epub 2015 May 11.

17.

FbsC, a novel fibrinogen-binding protein, promotes Streptococcus agalactiae-host cell interactions.

Buscetta M, Papasergi S, Firon A, Pietrocola G, Biondo C, Mancuso G, Midiri A, Romeo L, Teti G, Speziale P, Trieu-Cuot P, Beninati C.

J Biol Chem. 2014 Jul 25;289(30):21003-21015.

18.

Blood-brain barrier invasion by group B Streptococcus depends upon proper cell-surface anchoring of lipoteichoic acid.

Doran KS, Engelson EJ, Khosravi A, Maisey HC, Fedtke I, Equils O, Michelsen KS, Arditi M, Peschel A, Nizet V.

J Clin Invest. 2005 Sep;115(9):2499-507.

19.

Serine-rich repeat proteins and pili promote Streptococcus agalactiae colonization of the vaginal tract.

Sheen TR, Jimenez A, Wang NY, Banerjee A, van Sorge NM, Doran KS.

J Bacteriol. 2011 Dec;193(24):6834-42. doi: 10.1128/JB.00094-11. Epub 2011 Oct 7.

20.

[Occurrence of the hypervirulent ST-17 clone of Streptococcus agalactiae in pregnant women and newborns].

Brzychczy-Włoch M, Gosiewski T, Pawlik D, Szumała-Kakol A, Samead A, Heczko PB.

Przegl Epidemiol. 2012;66(3):395-401. Polish.

Supplemental Content

Support Center